Guojin Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Jiangsu Gibel Pharmaceutical Co., Ltd.
Apr 30 12:00 ET
Jiangsu Gibel Pharmaceutical Co., Ltd. Investor Relations Activity Record Form April 26, 2024
Apr 29 05:24 ET
Accountants' Response to the Issuer's Implementation Letter on the Issuer's Simple Procedure to Issue Shares to Specific Targets
Apr 25 12:00 ET
Announcement of Resolutions of the 6th Meeting of the Fourth Board of Supervisors of Gibbel
Apr 25 12:00 ET
Independent opinions of independent directors of Jiangsu Jebel Pharmaceutical Co., Ltd. on matters related to the sixth meeting of the fourth board of directors
Apr 25 12:00 ET
Special report on the storage and actual use of funds raised by Gibel in 2023
Apr 25 12:00 ET
Xinyong Zhonghe Certified Public Accountants (Special General Partnership) Audit Report on the Annual Storage and Use of Funds Raised by Jiangsu Gibel Pharmaceutical Co., Ltd. in 2023
Apr 25 12:00 ET
Gibbel 2023 Audit Report
Apr 25 12:00 ET
Responses from issuers and sponsors to the letter of implementation of the opinions of the Review Center on the Company's simplified procedure for issuing shares to specific targets
Apr 25 12:00 ET
Guojin Securities Co., Ltd. inspection opinions on the storage and use of funds raised by Jiangsu Gibel Pharmaceutical Co., Ltd. in 2023
Apr 25 12:00 ET
Special Audit Report of Xinyong Zhonghe Certified Public Accountants (Special General Partnership) on the summary of non-operating capital occupation and other related capital transactions of Jiangsu Gibel Pharmaceutical Co., Ltd.
Apr 25 12:00 ET
Jiangsu Gibel Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (He Di)
Apr 25 12:00 ET
Jiangsu Gibel Pharmaceutical Co., Ltd. 2023 Internal Control Audit Report
Apr 25 12:00 ET
Jiangsu Gibel Pharmaceutical Co., Ltd. evaluation report on the performance of accounting firms
Apr 25 12:00 ET
Jiangsu Gibel Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (Xie Zhuyun)
Apr 25 12:00 ET
Jiangsu Gibel Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (Yang Guoxiang)
Apr 25 12:00 ET
Guojin Securities Co., Ltd. site inspection report on the 2023 continuous supervision work of Jiangsu Gibel Pharmaceutical Co., Ltd.
Apr 25 12:00 ET
Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Directors of Gibbel
Apr 25 12:00 ET
Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Supervisors of Gibbel
Apr 25 12:00 ET
Audit opinion of the board of supervisors of Jiangsu Gibel Pharmaceutical Co., Ltd. on the authenticity, accuracy and completeness of the prospectus
Apr 25 12:00 ET
No Data
No Data